For the Quarter Ending March 2026
Amitriptyline Hydrochloride Prices in North America
- In United States, the Amitriptyline Hydrochloride Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock costs.
- In March 2026, consumer inflation reached 3.3% and producer prices climbed 4.0%, elevating Amitriptyline Hydrochloride Production Cost Trend.
- Industrial production grew 0.7% and the Manufacturing Index expanded in March 2026, supporting steady pharmaceutical formulation.
- Retail sales increased 4.0% and unemployment remained at 4.3% in March 2026, sustaining Amitriptyline Hydrochloride Demand Outlook.
- Consumer confidence rose to 91.8 in March 2026, ensuring consistent patient access to chronic healthcare medications.
- Benzene and phthalic anhydride feedstock costs spiked during Q1 2026, impacting the Amitriptyline Hydrochloride Price Forecast.
- Benzene feedstock inventories tightened significantly in March 2026 due to maintenance shutdowns and supply disruptions.
- Middle East shipping disruptions impacted chemical feedstock import flows throughout Q1 2026, straining supply chains.
- Downstream healthcare small molecule drug production stabilized in Q1 2026, maintaining consistent Amitriptyline Hydrochloride consumption.
Why did the price of Amitriptyline Hydrochloride change in March 2026 in North America?
- Benzene feedstock costs surged in March 2026 due to geopolitical tensions and regional maintenance shutdowns.
- Phthalic anhydride precursor supply faced severe constraints from tightening upstream availability during the Q1 2026.
- Middle East shipping route disruptions severely impacted chemical feedstock import flows throughout the Q1 2026.
Amitriptyline Hydrochloride Prices in APAC
- In China, the Amitriptyline Hydrochloride Price Index rose quarter-over-quarter in Q1 2026, driven by rising factory-gate prices.
- During March 2026, the Producer Price Index increased by 0.5% year-over-year, elevating Amitriptyline Hydrochloride Production Cost Trend.
- The Consumer Price Index rose 1.0% year-over-year in March 2026, maintaining a stable Amitriptyline Hydrochloride Demand Outlook.
- Industrial production grew 5.7% year-over-year in March 2026, ensuring ample intermediate supply for Amitriptyline Hydrochloride synthesis.
- The urban unemployment rate reached 5.4% in March 2026, driving clinical need and Amitriptyline Hydrochloride demand.
- The Manufacturing Index expanded in March 2026, reflecting robust production schedules for Amitriptyline Hydrochloride API synthesis.
- Phthalic anhydride feedstock costs inclined gradually in China during Q1 2026, impacting the Amitriptyline Hydrochloride Price Forecast.
- Brent crude surged in March 2026 following geopolitical disruptions, triggering upstream cost inflation for chemical precursors.
- China's pharmaceutical export sector expanded significantly in Q1 2026, fueling broader demand for Amitriptyline Hydrochloride APIs.
Why did the price of Amitriptyline Hydrochloride change in March 2026 in APAC?
- Phthalic anhydride feedstock costs inclined gradually in China during Q1 2026, increasing overall production expenses.
- Brent crude surged in March 2026, triggering upstream cost inflation across the regional petrochemical markets.
- The Producer Price Index increased by 0.5% in March 2026, elevating domestic factory-gate manufacturing costs.
Amitriptyline Hydrochloride Prices in Europe
- In Germany, the Amitriptyline Hydrochloride Price Index rose quarter-over-quarter in Q1 2026, driven by surging energy costs.
- The Consumer Price Index increased by 2.7% in March 2026, elevating Amitriptyline Hydrochloride Production Cost Trend.
- The Producer Price Index declined by -0.2% in March 2026, easing upstream chemical precursor expenses.
- The Manufacturing Index expanded in March 2026, supporting a robust Amitriptyline Hydrochloride Demand Outlook across sectors.
- Industrial production remained stagnant at 0.0% in February 2026, reflecting flat baseline activity for chemical manufacturing.
- Retail sales grew 0.7% and unemployment stayed at 4.2% in February 2026, sustaining prescription fulfillment rates.
- Consumer confidence registered at -24.7 in March 2026, leaving the baseline Amitriptyline Hydrochloride Price Forecast largely insulated.
- Mixed xylenes feedstock costs strengthened in February 2026, directly impacting the Amitriptyline Hydrochloride Price Index.
Why did the price of Amitriptyline Hydrochloride change in March 2026 in Europe?
- European natural gas spot prices surged in March 2026 due to Middle East shipping disruptions.
- Mixed xylenes feedstock costs strengthened in February 2026, directly increasing upstream chemical precursor manufacturing expenses.
- The Consumer Price Index rose 2.7% in March 2026, elevating operational and utility production costs.
For the Quarter Ending December 2025
Amitriptyline Hydrochloride Prices in North America
- In the United States, the Amitriptyline Hydrochloride Price Index rose quarter-over-quarter in Q4 2025, driven by elevated production costs.
- Amitriptyline Hydrochloride production costs increased during Q4 2025, influenced by a 3.0% year-over-year PPI rise in November 2025.
- Demand for Amitriptyline Hydrochloride remained stable in Q4 2025, supported by a 3.3% year-over-year retail sales increase in November 2025.
- The Amitriptyline Hydrochloride Price Index experienced upward pressure due to a 2.7% year-over-year CPI increase in December 2025.
- US feedstock costs, particularly natural gas, remained elevated throughout 2025, impacting Amitriptyline Hydrochloride manufacturing expenses.
- Healthcare spending and prescription drug spending expanded in 2025, supporting the Amitriptyline Hydrochloride demand outlook.
- Industrial production increased 2.0% year-over-year in December 2025, indicating stable broader chemical supply chains.
- The Prescription Drugs Index inched up in December 2025, reflecting sustained demand in the healthcare sector.
Why did the price of Amitriptyline Hydrochloride change in December 2025 in North America?
- Rising input costs, evidenced by a 3.0% year-over-year PPI increase in November 2025, elevated production expenses.
- A 2.7% year-over-year CPI increase in December 2025 contributed to higher raw material and energy costs.
- Stable demand, supported by a 4.4% unemployment rate in December 2025, allowed for price adjustments.
Amitriptyline Hydrochloride Prices in APAC
- In China, the Amitriptyline Hydrochloride Price Index fell quarter-over-quarter in Q4 2025, influenced by declining producer prices.
- Production costs decreased in December 2025, as the Producer Price Index declined 1.9% year-over-year.
- Demand faced headwinds in December 2025 due to weak retail sales growth of 0.9% year-over-year.
- Price Forecast suggests continued downward pressure, influenced by persistent chemical overcapacity in Q4 2025.
- Industrial production growth of 5.2% year-over-year in December 2025 supported stable supply chains.
- Manufacturing sentiment indicated expansion in December 2025, ensuring robust production capacity.
- Petrochemical feedstock costs influenced by persistent chemical sector overcapacity in October 2025.
- China's crude oil output and refinery throughput surged in 2025, ensuring ample upstream supply.
- Weak consumer confidence in Q4 2025 indirectly dampened overall pharmaceutical demand.
- China's chemical overcapacity reshaped global trade flows in October 2025, impacting market dynamics.
Why did the price of Amitriptyline Hydrochloride change in December 2025 in APAC?
- Producer prices declined by 1.9% year-over-year in December 2025, reducing input costs.
- Weak retail sales growth of 0.9% year-over-year in December 2025 indicated subdued consumer demand.
- Persistent chemical overcapacity in October 2025 exerted downward pressure on prices.
Amitriptyline Hydrochloride Prices in Europe
- In Germany, the Amitriptyline Hydrochloride Price Index declined quarter-over-quarter in Q4 2025, influenced by falling producer prices.
- Amitriptyline Hydrochloride production costs decreased in December 2025, as the Producer Price Index fell by 2.5% year-over-year.
- Demand outlook for Amitriptyline Hydrochloride faced headwinds in December 2025 due to contracting manufacturing activity.
- Consumer confidence remained pessimistic at -17.5 in December 2025, indirectly dampening overall healthcare demand.
- Operational costs for Amitriptyline Hydrochloride manufacturing increased in December 2025, with CPI rising 1.8% year-over-year.
- Industrial production grew modestly by 0.8% in October 2025, providing a stable foundation for pharmaceutical manufacturing.
- The unemployment rate stood at 6.2% in December 2025, potentially impacting patient access to prescribed medications.
- Retail sales increased by 1.1% in November 2025, supporting general healthcare demand in the stable economic environment.
Why did the price of Amitriptyline Hydrochloride change in December 2025 in Europe?
- Producer prices for industrial products declined by 2.5% in December 2025, reducing manufacturing input costs.
- Pessimistic consumer confidence at -17.5 in December 2025 indirectly dampened healthcare demand.
- Contracting Manufacturing Index in December 2025 signaled a weaker economic environment.
For the Quarter Ending September 2025
Amitriptyline Hydrochloride Prices in North America
- In the United States, Amitriptyline Hydrochloride Price Index rose in Q3 2025, driven by elevated production costs.
- Amitriptyline Hydrochloride production costs increased as the Producer Price Index rose 2.6% in August 2025.
- Demand for Amitriptyline Hydrochloride showed an upward trajectory in the US pharmaceutical market during Q3 2025.
- Natural gas feedstock costs, a key production driver, spiked in Q3 2025, increasing manufacturing expenses.
- Manufacturing inventories for chemical producers, including raw materials, shrank significantly in Q3 2025.
- The Consumer Price Index increased 3.0% in September 2025, impacting patient affordability for Amitriptyline Hydrochloride.
- US industrial production saw a slight 0.1% increase in September 2025, indicating subdued manufacturing activity.
- Retail sales, excluding auto and gas, rose 5.42% in September 2025, supporting overall healthcare spending.
- A stable unemployment rate of 4.3% in September 2025 supported healthcare access, despite declining consumer confidence to 94.2.
Why did the price of Amitriptyline Hydrochloride change in September 2025 in North America?
- Amitriptyline Hydrochloride production costs rose due to a 2.6% PPI increase in August 2025.
- Natural gas feedstock prices spiked in Q3 2025, elevating manufacturing expenses significantly.
- Manufacturing inventories shrank, and raw material levels turned negative in Q3 2025.
Amitriptyline Hydrochlorides Price in APAC
- In China, the Amitriptyline Hydrochloride Price Index fell quarter-over-quarter in Q3 2025, driven by weakening producer prices and chemical overcapacity.
- Amitriptyline Hydrochloride production costs decreased in Q3 2025, as China's Producer Price Index (PPI) fell 2.3% year-on-year.
- Demand outlook for Amitriptyline Hydrochloride is stable, supported by robust pharmaceutical market growth in Q3 2025.
- China's industrial production expanded 6.5% year-on-year in September 2025, supporting stable supply chains.
- Overall chemical feedstock costs eased in China during Q3 2025, contributing to lower production expenses.
- China's Manufacturing Index was contracting in September 2025, signaling a broader slowdown.
- Pharmaceutical and API exports from China strengthened in Q3 2025, indicating robust international demand.
- The broader chemical industry in China experienced significant overcapacity in Q3 2025, influencing market dynamics.
Why did the price of Amitriptyline Hydrochloride change in September 2025 in APAC?
- Producer Price Index (PPI) fell 2.3% year-on-year in September 2025, reducing manufacturing costs.
- China's broader chemical industry faced significant overcapacity in Q3 2025, increasing supply pressure.
- Deflationary pressures, with CPI falling 0.3% year-on-year in September 2025, impacted overall pricing.
Amitriptyline Hydrochlorides Price in Europe
- In Germany, the Amitriptyline Hydrochloride Price Index remained stable quarter-over-quarter in Q3 2025, influenced by mixed cost and demand signals.
- Amitriptyline Hydrochloride production costs experienced downward pressure in September 2025 due to a 1.7% decline in PPI year-over-year.
- Conversely, rising CPI by 2.4% year-over-year in September 2025 increased operational costs for manufacturers.
- Demand for Amitriptyline Hydrochloride remained consistent in Q3 2025, supported by Germany's aging population and chronic disease prevalence.
- The Manufacturing Index contracted in September 2025, indicating potential supply chain challenges for chemical precursors.
- European natural gas prices showed a steady downward trend in Q3 2025, easing energy-related production expenses.
- Benzene prices stabilized in early Q3 2025, while naphtha feedstock costs influenced o-xylene production trends.
- A low unemployment rate of 3.9% in September 2025 supported stable healthcare spending and patient access.
- The Amitriptyline Hydrochloride price forecast suggests continued stability, balancing cost pressures with inelastic pharmaceutical demand.
- Why did the price of Amitriptyline Hydrochloride change in September 2025 in Europe?
- Decreasing PPI by 1.7% in September 2025 reduced raw material and energy input costs for producers.
- Stable demand for essential pharmaceuticals, driven by an aging population in Q3 2025, provided price support.
- Rising CPI by 2.4% in September 2025 increased general operational expenses for manufacturing.
